ESSA Pharma Inc. 3 SEC Filings

Filed On	Filing
06 Jun 2023	Form 3: Merendino Lauren, Director
21 Sep 2022	Form 3: Kantoff Philip W., Director
21 Jul 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others Holds 4,712,590 shares of Common Stock
17 Aug 2021	Form 3: Biotech Growth N V, 10% owner and 1 other Holds 4,765,814 shares of Common Shares
02 Oct 2020	Form 3: Zweifach Sanford S, Director
02 Oct 2020	Form 3: Martin John Alexander, Director Holds 14,299 shares of Common Shares
01 Oct 2020	Form 3: Thorell Marella, Director Holds 2,881 shares of Common Shares
01 Oct 2020	Form 3: Clarus Lifesciences III, L.p., 10% owner and 7 others Holds 3,573,053 shares of Common Shares
01 Oct 2020	Form 3: Sollis Gary, Director
01 Oct 2020	Form 3: Cesano Alessandra, Chief Medical Officer
01 Oct 2020	Form 3: Wood David S., Chief Financial Officer Holds 22,890 shares of Common Shares
01 Oct 2020	Form 3: Virsik Peter, Chief Operating Officer Holds 12,570 shares of Common Shares
01 Oct 2020	Form 3: Brettman Ari David, Director
01 Oct 2020	Form 3: Berger Franklin M, Director Holds 858,037 shares of Common Shares
01 Oct 2020	Form 3: Glickman Richard M, Director Holds 38,750 shares of Common Shares
01 Oct 2020	Form 3: Requadt Scott, Director Holds 25,000 shares of Common Shares
01 Oct 2020	Form 3: Parkinson David Ross, Director Holds 25,070 shares of Common Shares

Comments